News

More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.

Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...

This is the first part of the 14th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by...

Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/

Why it matters: Confusing...

"MC0_8230" via Wikimedia Commons licensed under CC by 2.0 

This report documents a deliberate assault on disabled people in...

By Robert Weisman, The Boston Globe | 05.11.2016
Untitled Document

A trio of startup companies rooted in the local life-sciences community is focusing on a task long seen...

By Sharon Begley, STAT | 05.11.2016
Untitled Document

The largest study of its kind has found 74 genetic variants that influence how many years of school...

By Drew Endy and Laurie Zoloth, DSpace@MIT | 05.10.2016

At Harvard today an invitation-only group of mostly scientists, lawyers, and entrepreneurs, ~150 in total, met to discuss if and...

A woman and child stand in front of Sri Harmandir Sahib aka the Golden Temple in Amritsar, India. (Pixabay)
By Andrew Marszal, The Telegraph [UK] | 05.10.2016
Untitled Document An Indian woman has given birth to her first child at the age of 72 after undergoing fertility...
By Michael Cook, BioEdge | 05.07.2016
Untitled Document

What does the American public think about human germline enhancement? A survey of 17 polls taken over the...

By Antonio Regalado, MIT Technology Review | 05.06.2016

A treatment now pending approval in Europe will be the first commercial gene therapy to provide an outright cure for...

UniQure's Glybera aka alipogene tiparvovec.
By Antonio Regalado, MIT Technology Review | 05.05.2016
Untitled Document

The most expensive drug in history is a money loser that’s not reaching patients. In fact, it’s only been...

Daniel Kevles, Professor Emeritus of History, History of Medicine & American Studies, and Adjunct Professor, Law School, Yale University
By Emily McManus, TED Ideas | 05.05.2016
Untitled Document

An exploration of the ethics around CRISPR’s gene-snipping technology yields new insights on how to harness biotechnology that’s powerful enough to alter humanity.

In...